Volume 45, Issue S2 pp. S47-S59
REVIEW

Nutrition support for critically ill patients

Hasan M. Al-Dorzi MD

Hasan M. Al-Dorzi MD

College of Medicine, King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia

Search for more papers by this author
Yaseen M. Arabi MD

Corresponding Author

Yaseen M. Arabi MD

Intensive Care Department, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia

Correspondence

Yaseen M. Arabi, MD, Intensive Care Dep, King Abdulaziz Medical City, Riyadh, Saudi Arabia.

Email: [email protected]

Search for more papers by this author
First published: 13 December 2021
Citations: 10

This and other JPEN podcasts are available at https://nutritioncare.org/podcasts

Abstract

Nutrition support is an important aspect of the management of critically ill patients. This review highlights the emerging evidence on critical care nutrition and focuses on the pathophysiologic interplay between critical illness, the gastrointestinal tract, and nutrition support and the evidence on the best route, dose, and timing of nutrition. Although indirect calorimetry is recommended to measure energy expenditure, predictive equations are commonly used but are limited by their inaccuracy in individual patients. The current evidence supports early enteral nutrition (EN) in most patients, with a gradual increase in the daily dose over the first week. Delayed EN is warranted in patients with severe shock. According to recent trials, parenteral nutrition seems to be as effective as EN and may be started if adequate EN is not achieved by the first week of critical illness. A high protein dose has been recommended, but the best timing is unclear. Immuno-nutrition should not be routinely provided to critically ill patients. Patients receiving artificial nutrition should be monitored for metabolic derangements. Additional adequately powered studies are still needed to resolve many unanswered questions.

CONFLICT OF INTEREST

Yaseen M. Arabi is the principal investigator (PI) and Hasan M. Al-Dorzi is the co-investigator in the PI-initiated ongoing clinical trial “Replacing Protein via EN in a Stepwise Approach in Critically Ill Patients Randomized Controlled Trial-REPLENISH Trial” (ClinicalTrials.gov identifier: NCT04475666) sponsored by King Abdullah International Medical Research Center (KAIMRC).